Please assess the completion status of the following clinical trial:

Trial Title: Autologous Fibroblast Transplantation in Facial Deformities

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Available and willing to attend all follow-up visits.~* Age \> 18 years.~* Able and willing to give informed consent.~Exclusion Criteria:~* Known allergy or sensitivity to collagen fillers~* The subject has received a soft tissue augmentation to the area to be treated within the last 6 months.~* Subject is unwilling to forgo any cosmetic augmentation procedures for the duration of the study.~* The subject has received autologous fat transfer in the last 6 months.~* Subject is suffering from facial Kaposi's sarcoma.~* The subject has active skin diseases or inflammation on or near the area of injection~* positive HIV, HBV, HCV

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Fibroblast (Type: EXPERIMENTAL): Injection of autologous cultured fibroblast

Based on this trial design, predict the completion outcome and termination type (if applicable).